投融资数据库
免费查数据
注册送3天会员
首页>投融资
AltruBio
B轮
AltruBio, formerly known as AbGenomics, is a clinical stage biotechnology company focused on developing therapeutics for the potential treatment of immunological diseases.In April 2021, the company announced the completion of a USD 63 million Series A financing round.In October 2014, the company planned for an IPO in 2015.In October 2014, the company raised USD 16 million in a financing round.In June 2012, the company raised USD 11 million from a financing round, increasing the total raised since 2000 to USD 52 million
基本信息
-
公司全称AltruBio Inc
-
类型新型抗体疗法开发商
-
产业领域医药研发/制造、化学&生物药
-
公司人数15~50人
-
地址505 Montgomery Street 11th Floor San Francisco California; US;
-
联系电话16509889912
-
邮箱contact@abgenomics.com
-
成立时间2000-01-01
投融资
-
2024-05-21
-
2021-04-15
-
2013-07-18
相关投融资企业
E~PreIPO
Arthrosi Therapeutics LLC focuses on the treatment of uric acid levels and reduce joint damage for people living with gout.In July 2023, Arthrosi Therapeutics secured of $75 million in Series D financing
E~PreIPO
Arthrosi Therapeutics LLC focuses on the treatment of uric acid levels and reduce joint damage for people living with gout.In July 2023, Arthrosi Therapeutics secured of $75 million in Series D financing
收并购
Kronos Bio, Inc.于2017年6月2日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发新的癌症疗法，旨在通过针对失调转录的精确药物策略来改变患者的预后。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息